Effects of Chimonanthus nitens Oliv. Leaf Extract on Glycolipid Metabolism and Antioxidant Capacity in Diabetic Model Mice

Table 1

List of animal groups with different treatments.

Groups	Status and treatment
NC	Healthy, treated with 0.5% CMC-Na solution in equivalent volume to the test treatments
DM	Diabetic, treated with 0.5% CMC-Na solution in equivalent volume to the test treatments
COE-L	Diabetic, treated with low dose of Chimonanthus nitens Oliv. leaf extract (50 mg/kg body weight)
COE-H	Diabetic, treated with high dose of Chimonanthus nitens Oliv. leaf extract (200 mg/kg body weight)
ROS	Diabetic, treated with rosiglitazone (4 mg/kg body weight)

NC was normal control group, DM was diabetic model group, COE-L was low dose of Chimonanthus nitens Oliv. leaf extract group, COE-H was high dose of Chimonanthus nitens Oliv. leaf extract group, and ROS was rosiglitazone group. There were 8 animals in each group. Treatments were started after three days of streptozotocin injection.